Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider

Oslo, Norway, August 21, 2024 - Primary insider Martin Nicklasson, Chair of the Board of Nykode Therapeutics ASA, has today acquired 50,000 shares in Nykode Therapeutics ASA at an average price of NOK 5.65 per share. Following the transaction, Martin Nicklasson holds 142,000 shares in Nykode Therapeutics ASA.

Please see further details in the attached document.